Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms

19 Mar, 2021

Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Photo by Dmitry Vechorko on Unsplash

– Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
– The round was led by Dynamk Capital
– The investment will be used to scale its existing business and accelerate the development of new innovative human stem cell platforms, including its MantarrayTM platform.
– With this financing round, Curi Bio is welcoming Dr. Gustavo Mahler, Managing Partner at Dynamk Capital, as a new board member.

Biopharma Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: